Boston Scientific Corp.
Boston Scientific Corp. (BSX) — Form 8-K: Current report
AI-generated summary
Boston Scientific Corp. filed a current report announcing executive compensation and board changes on November 17, 2026. The board approved the 2027 Annual Bonus Plan and two performance share programs for executive officers. Additionally, the independent directors appointed David S. Wichmann as Lead Independent Director, effective January 1, 2027, succeeding Edward J. Ludwig.
Key facts
- Item 5.02 · Executive or director change or pay arrangement
- Item 8.01 · Other events
- Item 9.01 · Financial statements and exhibits
More BSX filings
- 8-K
Filed Nov 20, 2026
- FWP
Filed Nov 19, 2026
- FWP
Filed Nov 19, 2026
- 424B5
Filed Nov 19, 2026
- 424B5
Filed Nov 19, 2026
- 4
Filed Nov 6, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.